Rigel Pharmaceuticals Inc 10-Q for FY2022 Q3
Rigel Pharmaceuticals Inc (RIGL)
10-Q
2022-11-03
For: 2022-09-30
View Original
Added on
April 06, 2026
About this 10-Q
Rigel Pharmaceuticals Inc filed this 10-Q on November 3, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $22.41M
- up 4.0% from $21.54M a year earlier
- Net loss
- $19.04M
- compared with a net loss of $20.95M a year earlier
- Diluted EPS
- -$0.11
- compared with -$0.12 a year earlier